Rising healthcare habits such as smoking, increasing disposable income, rise in awareness among public and increasing strategic initiatives such as product launch or collaboration are key factors contributing to high CAGR of pigmentation disorders market during the forecast period.
Market Size – USD 5.35 Billion in 2018, Market Growth – CAGR of 8.4% Market Trends– Rising demand for non-invasive treatment and increased desire for flawless skincare expected to boost the market.
According to the current analysis of Reports and Data, the global Pigmentation Disorders Treatment Market valued at USD 5.35 billion in 2018 and is expected to reach USD 10.22 billion by the year 2026, at a CAGR of 8.4%. Pigmentation is the skin disorder formed because of the exceeding levels of melanin, a pigment made by melanocytes. The oxidation of tyrosine, which is an amino acid, results in the production of melanin. Keratinocytes carry melanin; although it is harmless, it creates a dullness in the skin. It mostly happens to the face and can also affect the other parts of the body. When melanocytes are affected, the melanin production of the body fluctuates. This defect either darkens or lightens the skin. Higher production of melanin results in the darkening of the skin, whereas less production of melanin makes the skin lighter. Hyperpigmentation is mostly seen in the Caucasian population, and smoking has also contributed to the growth of the market, the market is even expected to grow even more in the coming years.
Topical therapy includes Hydroquinone as a first-line agent also with a retinoid for treatment melasma due to its highest rate in the white population, which comprises 55 to 60% of the world population. Hormonal changes, pregnancy, and birth control pills are responsible for the occurrence of melasma in 90% of women throughout the world. Treatments like laser therapy and skin grafting methods, physical therapy in the form of lesion removal, photo-therapy are the other treatments used in pigmentation disorders.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2629
Further key findings from the report suggest
Key companies operating in the market include:
Bayer AG (Germany), Pierre Fabre Pharmaceuticals (France), EpiPharm AG (Swizzerland), SkinCeuticals International(US), Galderma laboratories (US), VIVIERPHARMA(Canada), Obagi Cosmeceuticals LLC (US)., La Roche-Posay, ALLERGAN (Dublin Ireland)
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2629
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Pigmentation Disorders market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Pigmentation Disorders industry, the market is segmented into:
Disease Condition Outlook
End Use Outlook
The regional analysis covers:
To know more about the report @ https://www.reportsanddata.com/report-detail/pigmentation-disorders-market
Benefits of Pigmentation Disorders Market Report:
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2629
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Related Reports :
Head of Business Development
Direct Line: +1-212-710-1370
Reports and Data | Web:www.reportsanddata.com